The Board of Directors of ConceptoMed AS announce the private placement of equity in ConceptoMed AS. Following the share issue, the number of Shareholders in the company amounts to 73 (previously 37). Gross proceeds from the private placement amounts to NOK 89.056.000 (approx. 9,4 MEUR), whereof 25,5 MNOK were subscribed by existing shareholders.
Since April 2012, Dehns has drafted and filed over 50 patent applications across 8 families, as well as a number of design registrations and trade marks. Patents have so far been granted in 4 families, and applications are pending in a number of territories including UK & Europe, PCT, USA, Brazil, Argentina, Australia, China, Hong Kong, India, South Korea, Singapore, Japan, Mexico, and Russia.
LUER-JACK APPROVED FOR SALE & MARKETING IN EUROPE (CE mark)
FIRST ORDERS OF LUER-JACK SHIPPING AFTER CE-MARK APPROVAL
ConceptoMed today announced that the company has received CE Mark approval for the Luer-Jack® syringe, a new and innovative medical syringe. Luer-Jack® is now ready for the European market and other large markets, where the CE mark allows for market entry.
This spring researchers at Great Ormond Street Hospital for Children in London, United Kingdom carried out a feasibility study to try out myShield in practice for children undergoing venepuncture procedures. Feedback was gathered from children aged 4-13 years, their parents, and healthcare professionals including nurses, healthcare assistants and play specialists. Fifty four children chose to […]
ConceptoMed has entered into an exclusive distribution agreement with Puls AS. Puls are a key player in the Norwegian healthcare market and provide capital equipment, medical tools and disposable medical devices to pharmacies, institutions, hospitals and other healthcare providers. Puls are the provider of Becton, Dickinson and Company products, including syringes, to the Norwegian market.
myShield® will be available in all Boots pharmacies in Norway and on www.boots.no from 1st of October 2015! A feasibility study done at one of the UK`s largest hospitals for children states that of the children who chose to use myShield® whilst they were having their blood taken, 94 % said myShield® made the procedure […]
ConceptoMed today announces that it has entered into an exclusive distribution agreement with Pennine Healthcare, one of the UK’s leading privately owned manufacturer of single use, sterile Medical Devices and Custom Procedure Packs, to launch and sell the Luer-Jack syringe in 10 countries in Europe and the Middle East Region.
From June 2014 to July 2015, The Norwegian Research Council (VRI) supported an evaluation research study on Luer-Jack®, a new medical syringe with one-hand disconnection from needles/cannulas and luer type connections. The Intervention Centre of Oslo University Hospital has conducted the study, and the final report was submitted to ConceptoMed today, 1st of September 2015.